CN106266758A - A kind of Chinese medicine formula treating blood deficiency - Google Patents
A kind of Chinese medicine formula treating blood deficiency Download PDFInfo
- Publication number
- CN106266758A CN106266758A CN201510340344.1A CN201510340344A CN106266758A CN 106266758 A CN106266758 A CN 106266758A CN 201510340344 A CN201510340344 A CN 201510340344A CN 106266758 A CN106266758 A CN 106266758A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- product
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 239000008280 blood Substances 0.000 title claims abstract description 20
- 210000004369 blood Anatomy 0.000 title claims abstract description 20
- 230000007812 deficiency Effects 0.000 title claims abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 29
- 201000010099 disease Diseases 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 241000756943 Codonopsis Species 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims abstract description 3
- 239000009636 Huang Qi Substances 0.000 claims abstract description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000002775 capsule Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 230000000857 drug effect Effects 0.000 claims description 2
- 235000013350 formula milk Nutrition 0.000 claims 7
- 239000002994 raw material Substances 0.000 claims 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 241000233805 Phoenix Species 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 235000012907 honey Nutrition 0.000 claims 1
- 208000004930 Fatty Liver Diseases 0.000 abstract description 9
- 206010019646 Hepatic cyst Diseases 0.000 abstract description 9
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 9
- 208000010706 fatty liver disease Diseases 0.000 abstract description 9
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 9
- 208000019255 Menstrual disease Diseases 0.000 abstract description 8
- 208000002173 dizziness Diseases 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 238000009472 formulation Methods 0.000 abstract description 3
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 210000000214 mouth Anatomy 0.000 abstract description 2
- 239000011800 void material Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 30
- 208000031973 Conjunctivitis infective Diseases 0.000 description 7
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 7
- 208000007117 Oral Ulcer Diseases 0.000 description 6
- 208000002399 aphthous stomatitis Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 208000008025 hordeolum Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000013403 hyperactivity Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000000321 herbal drug Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention is a kind of Chinese medicine formula treating blood deficiency, a kind of brand-new tcm product formula, belong to the field of Chinese medicines, the Chinese patent medicine product made with inventive formulation, cures mainly treatment menoxenia, the disease additionally caused men and women, old and young people's essence and blood cold and heat deficiency, as: that eye is dry and astringent, burst in oral cavity is foster, pin of stealing a glance, sitting watching for a long time cause dizziness, hepatic cyst fatty liver etc., particularly void is not mended, and rushes down the patient hindering unit, and taking this product has good curative effect.The constitutive material of the present invention comprises: the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Atractylodis, Radix Codonopsis, Poria, italian-jobi jen, Rhizoma Alismatis, Rhizoma Cyperi, the Radix Rehmanniae, the Radix Paeoniae Alba, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Puerariae, Radix Scutellariae, Fructus Lycii, Rhizoma Drynariae, Rhizoma Chuanxiong, Herba Taraxaci, Radix Paeoniae Rubra, Herba Leonuri, Fructus Jujubae, Caulis Spatholobi, Flos Carthami, Radix Glycyrrhizae.According to body deficiency and coldness, the different situations of excess-heat, early 9 points, evening 9 or point in afternoon 5,9 different times in evening are taked to take medicine.
Description
One, present disclosure belongs to the field of Chinese medicines, specifically, it is simply that a kind of brand-new tcm product formula；The a series of Chinese patent medicine product such as ball, scattered, cream, capsule, garment piece can be made.
Two, background technology
1, like product: SIWU TANG, QI and blood and, LVJIAO BUXUE KELI etc.；
2, Related product: Pilulae Fructus Sophorae, QIJU DIHUANG WAN etc.；
3 with similar and Related product comparable situation:
The present invention makes product compared with existing like product, greatly breach the limitation of contrast product, one is to be exceeded more than contrast like product twice by medicine suited-community, two is by medicine suited-community identical, effective percentage improves about twice, with SIWU TANG, QI and blood and as a example by, contrast product is merely adult female's emmenagogue, therefore single by medicine suited-community, quantity is the most limited, and product of the present invention not only can be with regulating menstruation, it is also suitable male's essence and blood and loses all symptoms, such as: insomnia, eyes watching for a long time is uncomfortable, dim-sighted, stay up late, dizzy, fatty liver, hepatic cyst, pink eye disease, steal a glance pin, long-term alcohol, burst to support and wait modern disease in oral cavity, men and women, old and young are all suitable for, and the disease of above symptom, take product effective percentage of the present invention (can feel to alleviate with visible symptom) and reach more than 80%；And SIWU TANG, QI and blood and, the like product such as LVJIAO BUXUE KELI, by medicine colony effective percentage, about 40%, (product is easily got angry, especially obvious to acidic physique side effect for it；And product of the present invention effectively overcomes, and these are not enough).
For another example, modern sees telecomputer for a long time, for the big Health Killer of modern one, play game, see news, finance, commercial affairs, the disease that the behaviors such as official documents and correspondence cause, 3 four one-tenth (and a lot of doctor does not recognize this pathogenic root) have been occupied in routine clinical outpatient service, before product invention of the present invention, I typically uses Pilulae Fructus Sophorae (removing heat from blood hepatoprotective of enriching blood) by clinic Chinese patent medicine, QIJU DIHUANG WAN, the drug combinations such as liver-protecting tablet, but efficiency is low, and formula for a product prepared slices of Chinese crude drugs decoction of the present invention, substantially can As the medicine took effect, the symptoms lessened (nearly 5 years, clinical thousands of cases in person, seldom accidentally drop, rehabilitation and have improvement ratio more than 95%), but decoction pieces is cumbersome, cost is high；After the present invention makes product, it is possible to effectively solve this problem.
4, the weak point of product of the present invention, therapeutic purposes emphasis, in medical treatment, promotes metabolism, excites autoimmune, and for severe blood deficiency adult female, rehabilitation speed is slightly slow, and treatment cycle is the longest, but after rehabilitation, health is more solid；Additionally it need to expand further in the scope of application of specified disease, to improve the effective percentage without the treatment of doctor's diagnosis and prescription.
5, crude drug of the present invention mostly is integration of edible and medicinal herbs material, after product is made in invention, effectively solves insufficiency of vital energy and blood, the disease that especially body constitution deficiency and coldness, and asthenic fire is vigorous, since changing always, the helpless situation that middle medical drugs " is mended then yang hyperactivity, rushed down, hinder unit ", is a revolutionary innovation to treatment modern disease.
Three, summary of the invention
1, goal of the invention: inventive formulation, after making product, can effectively solve menoxenia and the chloasma formed therefrom, mastalgia, all kinds of gynaecopathias etc., the most especially, innovation is the treatment aspect of Internal Diseases, the present invention makes disease and subhealth state that men and women's blood deficiency yang hyperactivity causes by product and can adapt to, and especially to treatment modern disease, plays the innovation effect for the treatment of both the principal and secondary aspects of a disease；
The targeted modern disease of the present invention refers to: because of sitting, watching for a long time, stay up late, have a sleepless night, drink, dyspepsia is got angry, monophagia causes malnutrition etc., outside gynaecopathia, such as fatty liver, hepatic cyst, oral ulcer, pink eye disease, dizziness and blurred vision, eyes hordeolum, dry swollen puckery etc..
The present invention makes the innovative principle of product, and modern disease generally causes with crossing to take advantage of because of the insufficiency of vital energy and blood of people, and product of the present invention effectively regulates QI and blood and the equilibrium between yin and yang of people, under the guidance of this principle, uses meridian tropism principle, quickly solves modern times commonly encountered diseases；And existing like product SIWU TANG, QI and blood and, LVJIAO BUXUE KELI etc., treat above-mentioned modern diseases and do not meet equilibrium between yin and yang principle because the body constitution of modern is compared with before three, 50 years, the most completely different.
2, present invention detailed annotation: the present invention makes product by following Chinese medicine composition, can use tradition and modern common process make ball, dissipate, the product such as cream, capsule, garment piece, prescription is as follows:
The Radix Astragali 9 grams, the Rhizoma Atractylodis Macrocephalae 6 grams, Rhizoma Atractylodis 6 grams, Radix Codonopsis 6 grams, 6 grams of Poria, italian-jobi jen 6 grams, Rhizoma Alismatis 6 grams, Rhizoma Cyperi 6 grams, 9 grams of the Radix Rehmanniae, the Radix Paeoniae Alba 9 grams, Radix Salviae Miltiorrhizae 9 grams, Radix Angelicae Sinensis 9 grams, Radix Puerariae 9 grams, Radix Scutellariae 9 grams, Fructus Lycii 9 grams, Rhizoma Drynariae 9 grams, Rhizoma Chuanxiong 9 grams, Herba Taraxaci 6 grams, Radix Paeoniae Rubra 6 grams, Herba Leonuri 9 grams, Fructus Jujubae 6 grams, Caulis Spatholobi 9 grams, 3 grams of Flos Carthami, 3 grams of Radix Glycyrrhizae.
Above dosage, non-specifically serious symptom, decoction can be as two days doses, and patent medicine can be as four days doses.
The formula of the present invention is constituted, and first observes the equilibrium between yin and yang principle of the traditional Chinese medical science, next to that monarch principle, is finally Meridian Tropism of Herbal Drugs principle.
Primarily with respect to equilibrium between yin and yang principle, the present invention fully takes into account medicine and enters patient body, produces the sick body equilibrium between yin and yang after medicine effect；Modern's overwhelming majority YANG QI deficiency, and patient produces asthenic fire yang hyperactivity because of various factors, product of the present invention is nourished simultaneously targetedly, yin nourishing pathogenic fire reducing；
Secondly about monarch principle, fill blood combination monarch drug, yin nourishing pathogenic fire reducing is soothing the liver ministerial drug, and regulating qi-flowing for strengthening spleen assistant of invigorating blood circulation makes；
Finally with respect to Meridian Tropism of Herbal Drugs principle, filling blood to lead and return kidney, liver, the heart, lung, pathogenic fire reducing is soothing the liver, and master returns liver, kidney, and regulating qi-flowing for strengthening spleen is invigorated blood circulation to lead and returned spleen, stomach, liver.
3, beneficial effect: product of the present invention, a primary innovation is to change the academic prejudice that Chinese medicine effect is slow and modern disease " is mended then yang hyperactivity, rushed down, hinder unit "；Such as oral ulcer, pink eye disease, eyes hordeolum, dizziness and blurred vision, eyes do the swollen obvious patient of disease such as puckery, and taking effect in one or two days after the tablet has been ingested, even three or five hours at once, uncomfortable disease is quickly taken a turn for the better.
Clinical laboratory data is broken down as follows:
(1) case selection: menoxenia, fatty liver and hepatic cyst, oral ulcer, pink eye disease and hordeolum (being commonly called as pin of stealing a glance):
(2) diagnostic criteria of disease: menoxenia refers to that menstruation in advance or is stepped back more than two days or, menstrual period the most very few through amount are more than 5 days or less than 4 days or dysmenorrhoea caking, dizziness etc.；Fatty liver and hepatic cyst refer generally to: mild or moderate, and patient oneself sensation is easily tired, find when routine physical examination (traditional Chinese medical science be visible news ask hit it is also seen that)；Oral ulcer refers to: oral erosion, blister etc.；Disease of eye refers to: pink eye disease, eyes are dry and astringent, hordeolum etc.；
(3) therapeutic scheme: above case inventive formulation makes ball (or dissipating) agent, middle hypopathia condition 9 points (after meal) sooner or later service once, severe patient's condition lunch one hour after adds and takes once (patient's condition alleviates and withdraws rear noon), within one week, is a course for the treatment of；Menoxenia, fatty liver and hepatic cyst need to control two to four courses for the treatment of, four to eight courses for the treatment of of severe patient；Other cases the most only need to be treated one to two courses for the treatment of；Further, according to body deficiency and coldness, the different situations of excess-heat, take 9 points morning, evening 9 or point in afternoon 5,9 different administration times in evening to regulate drug effect.
(4) the dizzy fatigue of efficacy assessment standard: 1, menoxenia is taken medicine a course for the treatment of, first sensation alleviates or disappears；Two dizzy substantially disappearing course for the treatment of, the mental status takes a turn for the better, and muscle power is good；Two to four the course for the treatment of health become better and better, if taken medicine after upper once official holiday, all have clear improvement through amount dysmenorrhoea etc. through the phase after four courses for the treatment of, mild or moderate menoxenia recovers normally (taking medicine from the beginning of having drowsiness phenomenon, rest well then recovers faster) substantially.2, fatty liver and hepatic cyst treat one to two courses for the treatment of, from the beginning of taking medicine one to three days, can constantly feel that comfort level improves, relevant issues such as eyes acid is swollen, rib dull pain, skelasthenia etc. take a turn for the better, treat two to four the course for the treatment of descendant the mental status be obviously improved, or sensation is basic recovers normal, then does instrument inspection, fatty liver and hepatic cyst are recovered or basic recovery normal (be wholly absent and think normal, recover 7-8 and become to think normal).3, oral ulcer, pink eye disease and hordeolum are taken medicine 1-3 days and are started onset, and a course for the treatment of is clearly better, and two courses for the treatment of recover substantially.
(5) data statistics: 1, menoxenia, inventor is clinical uninterrupted selects 100 examples, recovers normal 46 examples, hence it is evident that improve 43 examples, has taken a turn for the better 11, and completely ineffective do not have, effective percentage 100%；2, fatty liver and hepatic cyst, inventor's clinical uninterrupted selection 50 examples, recover normal 23 examples, hence it is evident that improve 19 examples, taken a turn for the better 5 examples, DeGrain 3 example, effective percentage 94%；3, oral ulcer, pink eye disease and hordeolum, inventor's clinical uninterrupted selection 50 examples, recover normal 41 examples, hence it is evident that improve 8 examples, DeGrain 1 example (suppurative ulcer), effective percentage 98%.
(6) conclusion: above case selected continuously for clinical a period of time, and inventor distinguishes disease medication, distinguish disease inaccurate in the case of effective percentage slightly lower, but ensure that effective percentage more than 90%；The present invention makes product total effective rate and degree applied widely, and inventor be sure of to reach and exceed " little Radix Bupleuri " level；Another classical patent medicine will be become.
Four, detailed description of the invention: tradition and modern common process can be used, make the product such as ball, scattered, cream, capsule, garment piece.
Claims (3)
1. treating a Chinese medicine formula for blood deficiency, a kind of brand-new tcm product formula, the Chinese medicine formula being made up of pure raw material of Chinese medicine, with existing
All kinds of Chinese medicinal formulaes and to make medicine the same, are all can to make Chinese patent medicine, the disease for the treatment of correlation type with herbal decoction piece；It is characterized in that permissible
Use tradition and modern common process to make the product such as ball, scattered, cream, capsule, garment piece, and make product named dragon and phoenix blood nest.
Chinese medicine formula the most according to claim 1, it is characterised in that the difference of its prescription, prescription is: the Radix Astragali 9 grams, the Rhizoma Atractylodis Macrocephalae 6 grams, grey
Art 6 grams, Radix Codonopsis 6 grams, 6 grams of Poria, italian-jobi jen 6 grams, Rhizoma Alismatis 6 grams, Rhizoma Cyperi 6 grams, 9 grams of the Radix Rehmanniae, the Radix Paeoniae Alba 9 grams, Radix Salviae Miltiorrhizae 9 grams, when
Return 9 grams, Radix Puerariae 9 grams, Radix Scutellariae 9 grams, Fructus Lycii 9 grams, Rhizoma Drynariae 9 grams, Rhizoma Chuanxiong 9 grams, Herba Taraxaci 6 grams, Radix Paeoniae Rubra 6 grams, Herba Leonuri 9 grams,
Fructus Jujubae 6 grams, Caulis Spatholobi 9 grams, 3 grams of Flos Carthami, 3 grams of Radix Glycyrrhizae.
Chinese medicine formula prescription the most according to claim 2 makes product, and be different from other kinds formula for a product is technically characterized in that raw material
Difference, raw material composition difference, raw material dosage is different, and consumption can be increased or decreased with equal proportion, and whole raw materials use without frying, process, adding honey
The raw cook decoction pieces that hydrochloric acid etc. are concocted, and can by body deficiency and coldness, the different situations of excess-heat, take early 9 points, evening 9 or point in afternoon 5,
Evening, 9 different administration times regulated drug effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510340344.1A CN106266758A (en) | 2015-06-10 | 2015-06-10 | A kind of Chinese medicine formula treating blood deficiency |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510340344.1A CN106266758A (en) | 2015-06-10 | 2015-06-10 | A kind of Chinese medicine formula treating blood deficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106266758A true CN106266758A (en) | 2017-01-04 |
Family
ID=57650741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510340344.1A Withdrawn CN106266758A (en) | 2015-06-10 | 2015-06-10 | A kind of Chinese medicine formula treating blood deficiency |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106266758A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107050306A (en) * | 2017-03-09 | 2017-08-18 | 刘岚 | A kind of Chinese medicine composition for being used to treat fatty liver |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2506307B2 (en) * | 1993-04-27 | 1996-06-12 | 中島 三夫 | Physiologically active agent |
| CN1785241A (en) * | 2005-07-28 | 2006-06-14 | 江西汇仁药业有限公司 | Motherwort quick dispersion solid prepn. and its prepn. method |
| CN103330121A (en) * | 2013-07-03 | 2013-10-02 | 山西大学 | Functional food for conditioning blood-insufficiency constitution and preparation method thereof |
| CN104189811A (en) * | 2014-08-15 | 2014-12-10 | 青岛市市立医院 | Traditional Chinese medicine composition for treating postpartum fainting and preparation method thereof |
-
2015
- 2015-06-10 CN CN201510340344.1A patent/CN106266758A/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2506307B2 (en) * | 1993-04-27 | 1996-06-12 | 中島 三夫 | Physiologically active agent |
| CN1785241A (en) * | 2005-07-28 | 2006-06-14 | 江西汇仁药业有限公司 | Motherwort quick dispersion solid prepn. and its prepn. method |
| CN103330121A (en) * | 2013-07-03 | 2013-10-02 | 山西大学 | Functional food for conditioning blood-insufficiency constitution and preparation method thereof |
| CN104189811A (en) * | 2014-08-15 | 2014-12-10 | 青岛市市立医院 | Traditional Chinese medicine composition for treating postpartum fainting and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 刘玉成: "《赐嗣：不孕症诊疗理论与实践》", 31 August 2007, 军事医学科学出版社 * |
| 季平: "补气活血法治疗肝癌术后18例疗效观察", 《河北中医》 * |
| 张梅香等: "辨证分型治疗原发性痛经68例观察", 《实用中医药杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107050306A (en) * | 2017-03-09 | 2017-08-18 | 刘岚 | A kind of Chinese medicine composition for being used to treat fatty liver |
| CN113797288A (en) * | 2017-03-09 | 2021-12-17 | 刘岚 | A Chinese medicinal composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526474B (en) | Chinese medicine composition for treating neurasthenia | |
| CN103800639A (en) | Medicinal composition with blood glucose reducing, blood lipid reducing and blood pressure lowering effects | |
| CN103536758A (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
| CN103386088A (en) | Chinese medicine composition for treating insomnia | |
| CN102406831B (en) | Chinese medicine composition for treating insomnia and dreamful sleep and preparation method of Chinese medicine composition | |
| CN101874879A (en) | Chinese medicinal composition for treating osteopyrexia and preparation method thereof | |
| CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN102512633B (en) | Traditional Chinese medicinal composition for treating insomnia | |
| CN103948888A (en) | Traditional Chinese medicinal preparation for treating neurasthenia | |
| CN103800888A (en) | Traditional Chinese medicine composition for treating neurasthenia | |
| CN102988616A (en) | Chinese medicinal composition for treating anemia | |
| CN102861189A (en) | Traditional Chinese medicine composition for treating viral encephalitis | |
| CN103550549B (en) | A kind of Chinese medicine composition for the treatment of deficiency of heart-yin | |
| CN102416146B (en) | Chinese medicinal composition for treating amenorrhea | |
| CN102512585B (en) | Traditional Chinese medicine used for treating yin deficiency and fire hyperactivity | |
| CN102406904B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN105079350A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN106266758A (en) | A kind of Chinese medicine formula treating blood deficiency | |
| CN100360152C (en) | Medicinal composition for treating insomnia and its preparing process | |
| CN102349979A (en) | Oral traditional Chinese medicine composition for treating bitter taste in mouth | |
| CN102441103B (en) | Medicine for treating insomnia | |
| CN102008638B (en) | Medicament for treating cardiac neurasthenia | |
| CN104888136A (en) | Traditional Chinese medicine composition for treatment of insomnia | |
| CN103736027A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN100496573C (en) | Oral traditional Chinese medicine for treating serious hyposomnia of breakdown of the normal physiological coordination between the heart and the kidney type |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Shixiang Document name: Notification of Publication of the Application for Invention |
|
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: 510520 Room 201, Dongyi street, Huangpi new village, Huangpi new village, Whampoa District, Guangzhou, Guangdong Applicant after: Wang Shixiang Address before: 523740 Guangdong Dongguan city Fenggang Yantian Yanming Lake Villa Room A2-20-104 Applicant before: Wang Shixiang |
|
| CB02 | Change of applicant information |
Address after: 510520 Room 201, Dongyi street, Huangpi new village, Huangpi new village, Whampoa District, Guangzhou, Guangdong Applicant after: Wang Shixiang Address before: 523740 Guangdong Dongguan city Fenggang Yantian Yanming Lake Villa Room A2-20-104 Applicant before: Wang Shixiang |
|
| CB02 | Change of applicant information | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170104 |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Shixiang Document name: Notice of conformity |
|
| DD01 | Delivery of document by public notice |